Kerry Ellen Flynn

Title: Kerry Ellen Flynn: Innovator in Genetic Analysis

Introduction

Kerry Ellen Flynn is a prominent inventor based in Grafton, MA (US). She has made significant contributions to the field of genetic analysis, particularly in relation to polycystic kidney disease. With a total of three patents to her name, Flynn's work has the potential to impact the diagnosis and treatment of this condition.

Latest Patents

Among her latest patents, Flynn has developed compositions and methods for genetic analysis of polycystic kidney disease. The subject invention relates to nucleic acid sequences for the detection of mutations in the PKD-1 or PKD-2 gene, as well as biomarkers for autosomal dominant polycystic kidney disease (ADPKD). The invention further includes methods for diagnosing ADPKD in individuals and kits for performing these methods. Additionally, it provides a method for determining the presence or absence of a mutant PKD gene in an individual.

Career Highlights

Kerry Ellen Flynn is currently associated with Athena Diagnostics, Inc., where she continues to advance her research and innovations. Her work is crucial in the ongoing efforts to improve genetic testing and diagnosis for polycystic kidney disease.

Collaborations

Flynn collaborates with notable colleagues, including Jeffrey George Jones and Aidan Noel Hennigan. These partnerships enhance the research and development of her innovative solutions in genetic analysis.

Conclusion

Kerry Ellen Flynn's contributions to genetic analysis, particularly in the context of polycystic kidney disease, highlight her role as a leading inventor in the field. Her patents and ongoing work at Athena Diagnostics, Inc. demonstrate her commitment to advancing medical science and improving patient outcomes.